Skip to content
Screener

Solventum SOLV EV / EBITDA

EV / EBITDA at other companies

Becton, Dickinson and Company logo
Becton, Dickinson and CompanyBDX
12.3×-6.5×
3M logo
3MMMM
15.7×+0.7×
Sanara MedTech Inc. logo
Sanara MedTech Inc.SMTI
19.2×-31.3×
Cardinal Health logo
Cardinal HealthCAH
16.9×+4.4×
UnitedHealth Group logo
UnitedHealth GroupUNH
12.8×-1.3×
DENTSPLY SIRONA logo
DENTSPLY SIRONAXRAY
107.7×

Other financials

Income statement

See full
Revenue$2.2B+2.2%
Gross profit$1.3B+9.4%
Operating income$181.0M-15.4%
Net income$92.0M+2.2%
EPS (diluted)$0.53+3.9%

Balance sheet

See full
Cash & equivalents$403.0M-18.1%
Total debt$5.8B-25.9%
Total equity$4.8B+31.7%
Total assets$14.2B-5.5%

Cash flow

See full
Operating cash flow$227.0M+34.3%
CapEx$83.0M-24.5%
Free cash flow-$273.0M-241%

Valuation

See full
Market cap$15.15B+20.6%
Enterprise value$20.54B+3.3%
P/E10.6×-22.5×
P/S1.8×+0.3×

Profitability

See full
Gross margin54.7%+0.2pp
Operating margin25%+15.7pp
Net margin17.3%+12.7pp
FCF margin4.6%-13.9pp

Returns & leverage

See full
Return on equity34%+22.3pp
Debt / equity1.2×-0.9×
Current ratio-0.2×

Where this comes from

Calculated from Solventum’s reported figures.

Based on the most recent quarter.

The source filing: Solventum’s 10-Q, filed August 5, 2026. Open the filing →

Filed
Aug 5, 2026, 5:27 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001964738-26-000047

FAQ

What is Solventum's EV / EBITDA?
Solventum (SOLV) reported EV / EBITDA of 7.3× in Q2 2026.
How has Solventum's EV / EBITDA changed year-over-year?
Solventum's EV / EBITDA decreased by 53.1% year-over-year, from 15.5× to 7.3×.
What does EV / EBITDA mean?
Enterprise value (market cap plus total debt minus cash) at the quarter end divided by trailing-twelve-month EBITDA. A capital-structure-neutral valuation multiple.

Ask your AI about Solventum's ev / ebitda.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude